Exicure, Inc, has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. on December 24, 2024, aimed at the acquisition...
Frost & Sullivan researched the bioinformatics-based drug discovery and development industry, and based on its analysis results, recognized DNAnexus, provider of the leading enterprise platform...
Adicet Bio, a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, announced the appointment...
Ikena Oncology, Inc, and Inmagene Biopharmaceuticals announced they have entered into a definitive merger agreement. In connection with the merger, Ikena has entered into...
ICL, a leading global specialty minerals company, announced its Board of Directors has approved the appointment of Elad Aharonson as ICL’s new president and...
